Even before the Covid pandemic gained nationwide attention, Reditus Laboratories had already positioned itself as a leading testing lab for podiatry. They had expanded into the fields of urology and histology testing. Histology tests are instrumental in helping doctors diagnose abnormalities in human cells or tissue, enabling the identification of specific microorganisms responsible for infections, diseases, and even cancer.
Reditus utilized state-of-the-art equipment and advanced clinical laboratory procedures to perform diagnostic tests on various samples, including skin biopsies, wound samples, and wart specimens. Their cutting-edge techniques enabled accurate diagnoses and offered valuable insights for treating diseases and injuries.
Reditus was initially established to provide pathology services to patients and clinicians. This type of diagnostic testing has a profound impact on all stages of patient care, from the initial diagnosis to the management of chronic diseases, as well as providing curative solutions for acute injuries or illnesses. The company's mission has always been focused on accurate and easily accessible laboratory testing with a fast turnaround time.
In addition to serving referred and walk-in patients, Reditus Labs became a national leader in Covid laboratory testing for universities and local school districts. They offered a comprehensive turnkey solution that included personal protective equipment, on-site testing staff, and a secure web-based portal for private access to test results.
Recognizing the importance of Covid booster shots for the country's economic recovery, Reditus maintained partnerships with corporate and government entities for on-site employee testing. The company understands that each site and population may present unique challenges and requirements. For this reason, they offered customized services and worked directly with HR departments to implement effective infectious disease testing and surveillance programs.
Following
